| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.52 | 3e-63 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.33 | 4e-28 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.44 | 4e-26 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-25 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.41 | 2e-17 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.28 | 4e-17 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.39 | 2e-15 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.32 | 2e-13 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-12 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-08 |